Results 301 to 310 of about 784,733 (395)
Cancer Proteomics: The State of the Art [PDF]
Paul C. Herrmann+2 more
openalex +1 more source
Review: Utility of mass spectrometry in rare disease research and diagnosis. [PDF]
Zhao T+5 more
europepmc +1 more source
Inspired by exercise‐induced metabolic rewiring and EV secretion, this study shows that in vivo metabolic engineering strategy can reprogram EV secretion pattern and simultaneously attenuate multiple tissue injury in CKD status, highlighting that it is a potential strategy for treating diverse chronic diseases.
Meng Zhao+11 more
wiley +1 more source
Proteomic Strategies on the Management of Phytopathogenic Fungi. [PDF]
Corrêa ANR, Ritter AC, Brandelli A.
europepmc +1 more source
The comprehensive proteomic and N‐glycoproteomic analyses of 45 colorectal cancer tissues with matched normal adjacent tissues identified 7125 intact N‐glycopeptides from 704 glycoproteins. A glycosylation site‐protein function network revealing metabolic dysregulation is constructed and a model differentiating tumors from normal tissues is developed ...
Guobin Liu+10 more
wiley +1 more source
Proteomic‐Based Approach for the Identification of Tumor Markers Associated with Hepatocellular Carcinoma [PDF]
Philip Shalhoub+3 more
openalex +1 more source
Plasma proteomics in pediatric patients with sepsis- hopes and challenges. [PDF]
Fan S, Zeng S.
europepmc +1 more source
This study investigates the integrated diagnostic and therapeutic strategy utilizing 89Zr/131I‐labeled tinurilimab for the management of malignant lung nodules, with a particular focus on lung adenocarcinoma (LUAD). CEACAM6, which is highly expressed in most LUAD patients, activates the Src/FAK signaling pathway, thereby promoting cell proliferation ...
Chongyang Chen+8 more
wiley +1 more source
Aided by FABP5, abnormally elevated asprosin in hepatocytes enters the nucleus, targets and inhibits PPARα binding to the CPT1A promoter, thereby suppressing FAO. Circulating asprosin exacerbates insulin resistance, collectively driving MASLD progression.
Yuan‐Yuan Yu+13 more
wiley +1 more source
Proteomics: From Protein Identification to Biological function
Jan van Oostrum+7 more
openalex +2 more sources